| Financial Year |
March 31 2022 |
| Monetary Funds |
38,022,414.53 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
179,303,625.19 |
| Advances to Suppliers |
173,556,549.65 |
| Other Receivables |
237,117,697.67 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
206,643,546.87 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
32,214,506.12 |
| Total Current Assets |
867,319,067.48 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
306,928,540.99 |
| Investment Properties |
-- |
| Fixed Assetes |
9,145,848.79 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
8,624,444.18 |
| R&D expenses |
1,447,121.54 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
11,095,219.65 |
| Deferred Income Tax Assets |
29,175,982.30 |
| Other Non-Current Assets |
104,926,469.88 |
| Sub-Total of Non-Current Assets |
489,436,698.73 |
| Total Assets |
1,356,755,766.21 |
| Short-Term Loans |
485,988,119.92 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
40,523,141.30 |
| Accounts Received In Advance |
-2,209,206.28 |
| Employee Compensation Payable |
5,228,363.06 |
| Taxes Payable |
103,602,672.42 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
224,296,175.21 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
161,921,369.09 |
| Other Current Liabilities |
363,512.08 |
| Sub-Total of Current Liabilities |
1,055,887,833.42 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
254,146,600.98 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
1,555,322.39 |
| Sub-Total of Non-Current Liabilities |
265,117,117.05 |
| Total Liabilities |
1,321,004,950.47 |
| Paid-In Capital(Or Share Stock) |
789,604,108.00 |
| Capital Surplus |
1,785,872,997.05 |
| Surplus Reserve |
24,695,629.51 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-2,603,372,880.12 |
| Minority Stockholder's Interest |
38,153,299.54 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-2,402,483.80 |
| Owner's Equity（Stockholder's Equity） |
35,750,815.74 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,356,755,766.21 |
